Israel 150 Logo

Israeli companies listed on US stock exchanges

Oramed Pharmaceuticals Inc. (ORMP)

Oramed Pharmaceuticals

Sector: Medical

Industry: Medical - Products

Exchange: Nasdaq

20 Mamilla Ave., 3rd Floor Jerusalem, 9414904, Israel

IR Contact info




Tel: +1-844-9-ORAMED

ORMP on Major Financial Platforms:
  • Nasdaq

Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006 and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection.

Oramed has an experienced management team with many years of business and pharmaceutical experience and is backed by world-class scientific experts.

Oramed's flagship product, an oral insulin capsule, has the potential to better the lives of millions of people around the world -  allowing, amongst other things, type 2 patients to begin insulin therapy earlier - without fear of needles.

Oramed's oral insulin is currently in clinical trials under the US FDA for the treatment of type 2 diabetes.

In addition to oral insulin, the Company's proprietary POD technology can potentially be used to orally administer a number of protein-based therapies, which are currently available only via injection.

The Executives
Nadav Kidron,Chairman, President & CEO
David Silberman,CFO
Josh Hexter,Chief Operating and Business Officer